They secrete cytokines that promote T-cell depletion while simultaneously reducing the capacity of CD8+and CD4+T cells to eradicate tumor cells within the TME, contributing to tumor progression, immune evasion of neoplastic cells, and resistance to cancer immunotherapy. This evidence concerns the gene CD8A and neoplasm.